Beatrice Mohelnikova-Duchonova

Beatrice Mohelnikova-Duchonova

UNVERIFIED PROFILE

Are you Beatrice Mohelnikova-Duchonova?   Register this Author

Register author
Beatrice Mohelnikova-Duchonova

Beatrice Mohelnikova-Duchonova

Publications by authors named "Beatrice Mohelnikova-Duchonova"

Are you Beatrice Mohelnikova-Duchonova?   Register this Author

33Publications

1399Reads

40Profile Views

Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study.

World J Surg Oncol 2019 Nov 6;17(1):182. Epub 2019 Nov 6.

Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, CZ-779 00, Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-019-1731-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836516PMC
November 2019

Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019 Aug 21. Epub 2019 Aug 21.

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5507/bp.2019.035DOI Listing
August 2019

Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.

Pharmacogenomics 2019 01 12;20(2):113-127. Epub 2018 Dec 12.

Department of Oncology, Faculty of Medicine & Dentistry, Palacky University Olomouc, University Hospital Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0073DOI Listing
January 2019

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Authors:
Alison P Klein Brian M Wolpin Harvey A Risch Rachael Z Stolzenberg-Solomon Evelina Mocci Mingfeng Zhang Federico Canzian Erica J Childs Jason W Hoskins Ashley Jermusyk Jun Zhong Fei Chen Demetrius Albanes Gabriella Andreotti Alan A Arslan Ana Babic William R Bamlet Laura Beane-Freeman Sonja I Berndt Amanda Blackford Michael Borges Ayelet Borgida Paige M Bracci Lauren Brais Paul Brennan Hermann Brenner Bas Bueno-de-Mesquita Julie Buring Daniele Campa Gabriele Capurso Giulia Martina Cavestro Kari G Chaffee Charles C Chung Sean Cleary Michelle Cotterchio Frederike Dijk Eric J Duell Lenka Foretova Charles Fuchs Niccola Funel Steven Gallinger J Michael M Gaziano Maria Gazouli Graham G Giles Edward Giovannucci Michael Goggins Gary E Goodman Phyllis J Goodman Thilo Hackert Christopher Haiman Patricia Hartge Manal Hasan Peter Hegyi Kathy J Helzlsouer Joseph Herman Ivana Holcatova Elizabeth A Holly Robert Hoover Rayjean J Hung Eric J Jacobs Krzysztof Jamroziak Vladimir Janout Rudolf Kaaks Kay-Tee Khaw Eric A Klein Manolis Kogevinas Charles Kooperberg Matthew H Kulke Juozas Kupcinskas Robert J Kurtz Daniel Laheru Stefano Landi Rita T Lawlor I-Min Lee Loic LeMarchand Lingeng Lu Núria Malats Andrea Mambrini Satu Mannisto Roger L Milne Beatrice Mohelníková-Duchoňová Rachel E Neale John P Neoptolemos Ann L Oberg Sara H Olson Irene Orlow Claudio Pasquali Alpa V Patel Ulrike Peters Raffaele Pezzilli Miquel Porta Francisco X Real Nathaniel Rothman Ghislaine Scelo Howard D Sesso Gianluca Severi Xiao-Ou Shu Debra Silverman Jill P Smith Pavel Soucek Malin Sund Renata Talar-Wojnarowska Francesca Tavano Mark D Thornquist Geoffrey S Tobias Stephen K Van Den Eeden Yogesh Vashist Kala Visvanathan Pavel Vodicka Jean Wactawski-Wende Zhaoming Wang Nicolas Wentzensen Emily White Herbert Yu Kai Yu Anne Zeleniuch-Jacquotte Wei Zheng Peter Kraft Donghui Li Stephen Chanock Ofure Obazee Gloria M Petersen Laufey T Amundadottir

Nat Commun 2018 02 8;9(1):556. Epub 2018 Feb 8.

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-02942-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805680PMC
February 2018

Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients.

J Cancer 2017 5;8(11):1959-1971. Epub 2017 Jul 5.

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 32300, Pilsen, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.19364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559956PMC
July 2017

Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2016 Dec 1;78(6):1101-1111. Epub 2016 Jun 1.

Department of Oncology, Palacky University Medical School and Teaching Hospital, IP Pavlova 6, 775 20, Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3058-yDOI Listing
December 2016

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.

Tumour Biol 2016 May 10;37(5):6823-30. Epub 2015 Dec 10.

Department of Oncology and Radiotherapy, Medical School and Teaching Hospital Pilsen, Charles University in Prague, alej Svobody 80, CZ-304 60, Pilsen, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-4523-7DOI Listing
May 2016

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

Int J Cancer 2015 Nov 19;137(9):2175-83. Epub 2015 Jun 19.

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548797PMC
November 2015

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Nat Genet 2015 Aug 22;47(8):911-6. Epub 2015 Jun 22.

1] Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. [2] Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520746PMC
August 2015

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.

World J Gastroenterol 2014 Aug;20(30):10316-30

Beatrice Mohelnikova-Duchonova, Pavel Soucek, Department of Toxicogenomics, National Institute of Public Health, 10042 Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i30.10316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130839PMC
August 2014

Human equilibrative nucleoside transporter 1 (hENT1): do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?

Pancreatology 2013 Nov-Dec;13(6):558-63. Epub 2013 Oct 10.

Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic; Biomedical Centre, Faculty of Medicine in Plzen, Charles University in Prague, Plzen, Czech Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2013.09.005DOI Listing
July 2014

Role of solute carrier transporters in pancreatic cancer: a review.

Pharmacogenomics 2014 Jun;15(8):1133-45

Department of Oncology, Palacky University Medical School & Teaching Hospital, Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.14.80DOI Listing
June 2014

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

Cancer Chemother Pharmacol 2013 Sep 11;72(3):669-82. Epub 2013 Aug 11.

Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, Prague 10, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2246-2DOI Listing
September 2013

The association of taxane resistance genes with the clinical course of ovarian carcinoma.

Genomics 2013 Aug 28;102(2):96-101. Epub 2013 Mar 28.

Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygeno.2013.03.005DOI Listing
August 2013

CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.

Cancer Epidemiol 2010 Oct;34(5):656-8

Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2010.06.008DOI Listing
October 2010

CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.

Pancreas 2010 Mar;39(2):144-8

Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0b013e3181bab6c2DOI Listing
March 2010